Dianthus Therapeutics (DNTH) Total Liabilities (2017 - 2025)
Historic Total Liabilities for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $31.0 million.
- Dianthus Therapeutics' Total Liabilities rose 8954.74% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.0 million, marking a year-over-year increase of 8954.74%. This contributed to the annual value of $21.5 million for FY2024, which is 10437.59% up from last year.
- Per Dianthus Therapeutics' latest filing, its Total Liabilities stood at $31.0 million for Q3 2025, which was up 8954.74% from $23.0 million recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Total Liabilities peaked at $43.2 million during Q1 2022, and registered a low of $4.0 million during Q2 2023.
- In the last 4 years, Dianthus Therapeutics' Total Liabilities had a median value of $16.3 million in 2024 and averaged $19.9 million.
- In the last 5 years, Dianthus Therapeutics' Total Liabilities plummeted by 8977.26% in 2023 and then soared by 16626.18% in 2024.
- Quarter analysis of 4 years shows Dianthus Therapeutics' Total Liabilities stood at $9.5 million in 2022, then grew by 11.43% to $10.5 million in 2023, then skyrocketed by 104.38% to $21.5 million in 2024, then skyrocketed by 43.94% to $31.0 million in 2025.
- Its Total Liabilities stands at $31.0 million for Q3 2025, versus $23.0 million for Q2 2025 and $20.0 million for Q1 2025.